206 related articles for article (PubMed ID: 19365400)
1. A novel CYP2A6 allele (CYP2A6*35) resulting in an amino-acid substitution (Asn438Tyr) is associated with lower CYP2A6 activity in vivo.
Al Koudsi N; Ahluwalia JS; Lin SK; Sellers EM; Tyndale RF
Pharmacogenomics J; 2009 Aug; 9(4):274-82. PubMed ID: 19365400
[TBL] [Abstract][Full Text] [Related]
2. Novel and established CYP2A6 alleles impair in vivo nicotine metabolism in a population of Black African descent.
Mwenifumbo JC; Al Koudsi N; Ho MK; Zhou Q; Hoffmann EB; Sellers EM; Tyndale RF
Hum Mutat; 2008 May; 29(5):679-88. PubMed ID: 18360915
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive evaluation of variability in nicotine metabolism and CYP2A6 polymorphic alleles in four ethnic populations.
Nakajima M; Fukami T; Yamanaka H; Higashi E; Sakai H; Yoshida R; Kwon JT; McLeod HL; Yokoi T
Clin Pharmacol Ther; 2006 Sep; 80(3):282-97. PubMed ID: 16952495
[TBL] [Abstract][Full Text] [Related]
4. Characterization of novel CYP2A6 polymorphic alleles (CYP2A6*18 and CYP2A6*19) that affect enzymatic activity.
Fukami T; Nakajima M; Higashi E; Yamanaka H; Sakai H; McLeod HL; Yokoi T
Drug Metab Dispos; 2005 Aug; 33(8):1202-10. PubMed ID: 15900015
[TBL] [Abstract][Full Text] [Related]
5. A novel polymorphism of human CYP2A6 gene CYP2A6*17 has an amino acid substitution (V365M) that decreases enzymatic activity in vitro and in vivo.
Fukami T; Nakajima M; Yoshida R; Tsuchiya Y; Fujiki Y; Katoh M; McLeod HL; Yokoi T
Clin Pharmacol Ther; 2004 Dec; 76(6):519-27. PubMed ID: 15592323
[TBL] [Abstract][Full Text] [Related]
6. Ethnic variation in CYP2A6*7, CYP2A6*8 and CYP2A6*10 as assessed with a novel haplotyping method.
Mwenifumbo JC; Myers MG; Wall TL; Lin SK; Sellers EM; Tyndale RF
Pharmacogenet Genomics; 2005 Mar; 15(3):189-92. PubMed ID: 15861044
[TBL] [Abstract][Full Text] [Related]
7. A novel CYP2A6 allele, CYP2A6*23, impairs enzyme function in vitro and in vivo and decreases smoking in a population of Black-African descent.
Ho MK; Mwenifumbo JC; Zhao B; Gillam EM; Tyndale RF
Pharmacogenet Genomics; 2008 Jan; 18(1):67-75. PubMed ID: 18216723
[TBL] [Abstract][Full Text] [Related]
8. CYP2A7 polymorphic alleles confound the genotyping of CYP2A6*4A allele.
Fukami T; Nakajima M; Sakai H; McLeod HL; Yokoi T
Pharmacogenomics J; 2006; 6(6):401-12. PubMed ID: 16636685
[TBL] [Abstract][Full Text] [Related]
9. Differences between Spaniards and Ecuadorians in CYP2A6 allele frequencies: comparison with other populations.
Soriano A; Vicente J; Carcas C; Gonzalez-Andrade F; Arenaz I; Martinez-Jarreta B; Fanlo A; Mayayo E; Sinués B
Fundam Clin Pharmacol; 2011 Oct; 25(5):627-32. PubMed ID: 21410749
[TBL] [Abstract][Full Text] [Related]
10. A novel CYP2A6*20 allele found in African-American population produces a truncated protein lacking enzymatic activity.
Fukami T; Nakajima M; Higashi E; Yamanaka H; McLeod HL; Yokoi T
Biochem Pharmacol; 2005 Sep; 70(5):801-8. PubMed ID: 15993850
[TBL] [Abstract][Full Text] [Related]
11. Novel CYP2A6 variants identified in African Americans are associated with slow nicotine metabolism in vitro and in vivo.
Piliguian M; Zhu AZ; Zhou Q; Benowitz NL; Ahluwalia JS; Sanderson Cox L; Tyndale RF
Pharmacogenet Genomics; 2014 Feb; 24(2):118-28. PubMed ID: 24305170
[TBL] [Abstract][Full Text] [Related]
12. Use of a predictive model derived from in vivo endophenotype measurements to demonstrate associations with a complex locus, CYP2A6.
Bloom AJ; Harari O; Martinez M; Madden PA; Martin NG; Montgomery GW; Rice JP; Murphy SE; Bierut LJ; Goate A
Hum Mol Genet; 2012 Jul; 21(13):3050-62. PubMed ID: 22451501
[TBL] [Abstract][Full Text] [Related]
13. CYP2A6 and CYP2E1 polymorphisms in a Brazilian population living in Rio de Janeiro.
Rossini A; Lima SS; Rapozo DC; Faria M; Albano RM; Pinto LF
Braz J Med Biol Res; 2006 Feb; 39(2):195-201. PubMed ID: 16470306
[TBL] [Abstract][Full Text] [Related]
14. An in vivo pilot study characterizing the new CYP2A6*7, *8, and *10 alleles.
Xu C; Rao YS; Xu B; Hoffmann E; Jones J; Sellers EM; Tyndale RF
Biochem Biophys Res Commun; 2002 Jan; 290(1):318-24. PubMed ID: 11779172
[TBL] [Abstract][Full Text] [Related]
15. The contribution of common CYP2A6 alleles to variation in nicotine metabolism among European-Americans.
Bloom J; Hinrichs AL; Wang JC; von Weymarn LB; Kharasch ED; Bierut LJ; Goate A; Murphy SE
Pharmacogenet Genomics; 2011 Jul; 21(7):403-16. PubMed ID: 21597399
[TBL] [Abstract][Full Text] [Related]
16. A novel single nucleotide polymorphism altering stability and activity of CYP2a6.
Ariyoshi N; Sawamura Y; Kamataki T
Biochem Biophys Res Commun; 2001 Mar; 281(3):810-4. PubMed ID: 11237731
[TBL] [Abstract][Full Text] [Related]
17. New CYP2A6 gene deletion and conversion variants in a population of Black African descent.
Mwenifumbo JC; Zhou Q; Benowitz NL; Sellers EM; Tyndale RF
Pharmacogenomics; 2010 Feb; 11(2):189-98. PubMed ID: 20136358
[TBL] [Abstract][Full Text] [Related]
18. A novel duplication type of CYP2A6 gene in African-American population.
Fukami T; Nakajima M; Yamanaka H; Fukushima Y; McLeod HL; Yokoi T
Drug Metab Dispos; 2007 Apr; 35(4):515-20. PubMed ID: 17267622
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cytochrome P450 2A6 polymorphism frequencies in Caucasians and African-Americans using a new one-step PCR-RFLP genotyping method.
Paschke T; Riefler M; Schuler-Metz A; Wolz L; Scherer G; McBride CM; Bepler G
Toxicology; 2001 Nov; 168(3):259-68. PubMed ID: 11684323
[TBL] [Abstract][Full Text] [Related]
20. Effects of polymorphism in promoter region of human CYP2A6 gene (CYP2A6*9) on expression level of messenger ribonucleic acid and enzymatic activity in vivo and in vitro.
Yoshida R; Nakajima M; Nishimura K; Tokudome S; Kwon JT; Yokoi T
Clin Pharmacol Ther; 2003 Jul; 74(1):69-76. PubMed ID: 12844137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
